GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) » Definitions » Other Net Income (Loss)

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Other Net Income (Loss) : Rp0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is PT Industri Jamu dan Farmasi Sido Muncul Tbk Other Net Income (Loss)?

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Other Net Income (Loss) for the three months ended in Mar. 2024 was Rp0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was Rp0 Mil.


PT Industri Jamu dan Farmasi Sido Muncul Tbk Other Net Income (Loss) Historical Data

The historical data trend for PT Industri Jamu dan Farmasi Sido Muncul Tbk's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Other Net Income (Loss) Chart

PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Industri Jamu dan Farmasi Sido Muncul Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PT Industri Jamu dan Farmasi Sido Muncul Tbk Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Industri Jamu dan Farmasi Sido Muncul Tbk Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of PT Industri Jamu dan Farmasi Sido Muncul Tbk's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Gajahmada No. 123, 1st Floor, Gedung Hotel Tentrem, Office Sido Muncul, Lantai 1, Semarang, IDN, 50134
PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Headlines

No Headlines